New York-based genetics startup, Nucleus Genomics, is pushing the boundaries of personal medicine, offering potential parents a unique service using whole-genome data to generate ‘polygenic’ risk scores. These scores provide parents with predictions on their embryo’s intelligence, height, appearance, potential lifespan, and probabilities for common diseases like cancer and Alzheimer’s. Despite the limited accuracy of […]